Market By Technology, Application, Component, End-user, And Geography | Forecast 2019-2027
Triton’s research report on the Europe 3D cell culture market has estimated the industry to show an upward trend in terms of revenue, with a CAGR of 11.96% during the forecasting years of 2019-2027.
The countries scrutinized in the European 3D cell culture market are:
• Russia
• Germany
• Italy
• Spain
• France
• The UK
• Rest of Europe
Report scope can be customized per your requirements. Request For Customization
Biologists have started adopting 3D cellular models owing to the extensive applications of 3D cell culture for several research purposes, including tissue engineering, cancer biology, and stem cell, among others. This has been instrumental in generating revenue for the 3D cell culture market in Europe. In addition, several market players joining forces for the development of this technology are contributing to market growth.
In Germany, workshops and conducted by and organizations and institutes engaged in 3D cell culture conduct training programs and workshops with the intent of raising awareness of 3D cell cultures, which would help in augmenting the growth of the country’s 3D cell culture market. Conferences conducted to promote the adoption of this technology, along with aid from the government for biological research, are boosting Germany’s 3D cell culture market.
Innovations in stem cell research and regenerative medicine are have proven to be viable in the treatment of debilitating diseases and other such conditions. There is a wide-scale adoption of regenerative medicine and stem cell therapies in France. Besides, the country has a robust healthcare infrastructure. Studies have shown a decrease in the incidence of cancer deaths in recent years, which can be attributed to proactive efforts by the government, which impacts France’s 3D cell culture market.
Tecan Group Ltd. is a provider of laboratory instruments and solutions for university research departments, pharma & biotech companies, and forensic and diagnostic laboratories. The company also offers liquid handling platforms; microplate readers, washers, and stackers; and automated microplate & microarray instruments – such as multifunctional, modular, and upgradeable systems. In addition, it develops and manufactures sample preparation for mass spectrometry and immunoassays for specialty diagnostics. In March 2019, Tecan Group collaborated with QIAGEN to improve the processing of the latter’s QFT-Plus diagnostic test with the help of Tecan’s laboratory automation workstation, Fluent®. The Switzerland-based company is headquartered in Männedorf.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
3D CELL CULTURE MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. MARKET
DEFINITION
2.2. PORTER’S
FIVE FORCES MODEL
2.2.1. THREAT
OF NEW ENTRANTS
2.2.2. THREAT
OF SUBSTITUTE
2.2.3. BARGAINING
POWER OF BUYERS
2.2.4. BARGAINING
POWER OF SUPPLIERS
2.2.5. THREAT
OF COMPETITIVE RIVALRY
2.3. ECONOMIC
TECHNOLOGICAL, AND POLITICAL & LEGAL OUTLOOK
2.4. REGULATORY
OUTLOOK
2.5. KEY
INSIGHT
2.6. MARKET
ATTRACTIVENESS INDEX
2.7. MARKET
DRIVERS
2.7.1. GROWING
CANCER PREVALENCE
2.7.2. HIGH
DEMAND FOR ORGAN TRANSPLANTATION
2.7.3. PROMISING
DEVELOPMENTS USING REGENERATIVE MEDICINE
2.8. MARKET
RESTRAINTS
2.8.1. LACK
OF SKILLED PROFESSIONALS
2.8.2. INCOMPATIBILITIES
OF THE PREFERRED ANALYTICAL TECHNOLOGIES WITH 3D CELL CULTURE
2.9. MARKET
OPPORTUNITIES
2.9.1. INCREASING
USAGE OF 3D CELL CULTURE IN ORGAN TRANSPLANTATION AND DRUG SCREENING
2.9.2. TECHNOLOGICAL
ADVANCEMENT
2.10.
MARKET CHALLENGES
2.10.1.
LACK OF AVAILABILITY OF DATA
FOR RESEARCH ON 3D CELL CULTURE
2.10.2.
CHALLENGES ASSOCIATED WITH 3D
CELL CULTURE IN PERFORMING EXPERIMENTS
3. 3D
CELL CULTURE MARKET OUTLOOK – BY TECHNOLOGY
3.1. SCAFFOLD-BASED
3.1.1. HYDROGELS
3.1.2. POLYMERIC
SCAFFOLDS
3.1.3. MICROPATTERNED
SURFACE MICROPLATES
3.2. SCAFFOLD-FREE
3.2.1. HANGING
DROP MICROPLATES
3.2.2. SPHEROID
MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING
3.2.3. MICROFLUIDIC
3D CELL CULTURE
3.2.4. MAGNETIC
LEVITATIONS & 3D BIOPRINTING
3.3. 3D
BIOREACTORS
4. 3D
CELL CULTURE MARKET OUTLOOK – BY APPLICATION
4.1. CANCER
4.2. TISSUE
ENGINEERING & IMMUNOHISTOCHEMISTRY
4.3. DRUG
DEVELOPMENT
4.4. STEM
CELL RESEARCH
4.5. OTHER
APPLICATIONS
5. 3D
CELL CULTURE MARKET OUTLOOK – BY COMPONENT
5.1. MEDIA
5.2. REAGENTS
AND CONSUMABLES
6. 3D
CELL CULTURE MARKET OUTLOOK – BY END-USER
6.1. BIOTECHNOLOGY
AND PHARMACEUTICAL ORGANIZATIONS
6.2. RESEARCH
LABORATORIES AND INSTITUTES
6.3. HOSPITALS
AND DIAGNOSTIC CENTERS
6.4. OTHER
END-USERS
7. 3D
CELL CULTURE MARKET – REGIONAL OUTLOOK
7.1. EUROPE
7.1.1. COUNTRY
ANALYSIS
7.1.1.1. GERMANY
7.1.1.2. THE
UNITED KINGDOM
7.1.1.3. FRANCE
7.1.1.4. SPAIN
7.1.1.5. ITALY
7.1.1.6. RUSSIA
7.1.1.7. REST
OF EUROPE
8. COMPANY
PROFILES
8.1. BECTON
DICKINSON AND COMPANY
8.2. TECAN
GROUP LTD.
8.3. PROMOCELL
GMBH
8.4. CORNING
INC.
8.5. NANO3D
BIOSCIENCES, INC.
8.6. 3D
BIOTEK, LLC
8.7. MERCK
KGAA
8.8. EMULATE
8.9. THERMO
FISHER SCIENTIFIC INC.
8.10.
GE HEALTHCARE
8.11.
INSPHERO
8.12.
LONZA GROUP AG
8.13.
VWR CORPORATION
8.14.
SYNTHECON, INCORPORATED
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.1.1. OBJECTIVES
OF STUDY
9.1.2. SCOPE
OF STUDY
9.2. SOURCES
OF DATA
9.2.1. PRIMARY
DATA SOURCES
9.2.2. SECONDARY
DATA SOURCES
9.3. RESEARCH
METHODOLOGY
9.3.1. EVALUATION
OF PROPOSED MARKET
9.3.2. IDENTIFICATION
OF DATA SOURCES
9.3.3. ASSESSMENT
OF MARKET DETERMINANTS
9.3.4. DATA
COLLECTION
9.3.5. DATA
VALIDATION & ANALYSIS
TABLE 1 EUROPE 3D CELL CULTURE MARKET 2019-2027
($ MILLION)
TABLE 2 EUROPE 3D CELL CULTURE MARKET BY
TECHNOLOGY 2019-2027 ($ MILLION)
TABLE 3 EUROPE SCAFFOLD-BASED MARKET BY TYPE
2019-2027 ($ MILLION)
TABLE 4 EUROPE SCAFFOLD-FREE MARKET BY TYPE
2019-2027 ($ MILLION)
TABLE 5 EUROPE 3D CELL CULTURE MARKET BY
APPLICATION 2019-2027 ($ MILLION)
TABLE 6 EUROPE 3D CELL CULTURE MARKET BY
COMPONENT 2019-2027 ($ MILLION)
TABLE 7 USAGE OF MEDIA IN DIFFERENT STAGES OF
ORGANOIDS FORMATION
TABLE 8 EUROPE 3D CELL CULTURE MARKET BY
END-USER 2019-2027 ($ MILLION)
TABLE 9 EUROPE 3D CELL CULTURE MARKET BY COUNTRY
2019-2027 ($ MILLION)
FIGURE 1 EUROPE 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 2 EUROPE 3D CELL CULTURE MARKET BY
SCAFFOLD-BASED 2019-2027 ($ MILLION)
FIGURE 3 EUROPE 3D CELL CULTURE MARKET BY HYDROGELS
2019-2027 ($ MILLION)
FIGURE 4 EUROPE 3D CELL CULTURE MARKET BY POLYMERIC
SCAFFOLDS 2019-2027 ($ MILLION)
FIGURE 5 EUROPE 3D CELL CULTURE MARKET BY
MICROPATTERNED SURFACE MICROPLATES 2019-2027 ($ MILLION)
FIGURE 6 EUROPE 3D CELL CULTURE MARKET BY
SCAFFOLD-FREE 2019-2027 ($ MILLION)
FIGURE 7 EUROPE 3D CELL CULTURE MARKET BY HANGING
DROP MICROPLATES 2019-2027 ($ MILLION)
FIGURE 8 EUROPE 3D CELL CULTURE MARKET BY SPHEROID
MICROPLATES CONTAINING ULTRA-LOW ATTACHMENT (ULA) COATING 2019-2027 ($ MILLION)
FIGURE 9 EUROPE 3D CELL CULTURE MARKET BY
MICROFLUIDIC 3D CELL CULTURE 2019-2027 ($ MILLION)
FIGURE 10 EUROPE 3D CELL CULTURE MARKET BY MAGNETIC
LEVITATIONS & 3D BIOPRINTING 2019-2027 ($ MILLION)
FIGURE 11 EUROPE 3D CELL CULTURE MARKET BY 3D
BIOREACTORS 2019-2027 ($ MILLION)
FIGURE 12 EUROPE 3D CELL CULTURE MARKET BY CANCER
2019-2027 ($ MILLION)
FIGURE 13 EUROPE 3D CELL CULTURE MARKET BY TISSUE
ENGINEERING & IMMUNOHISTOCHEMISTRY 2019-2027 ($ MILLION)
FIGURE 14 EUROPE 3D CELL CULTURE MARKET BY DRUG
DEVELOPMENT 2019-2027 ($ MILLION)
FIGURE 15 EUROPE 3D CELL CULTURE MARKET BY STEM CELL
RESEARCH 2019-2027 ($ MILLION)
FIGURE 16 EUROPE 3D CELL CULTURE MARKET BY OTHER
APPLICATIONS 2019-2027 ($ MILLION)
FIGURE 17 EUROPE 3D CELL CULTURE MARKET BY MEDIA
2019-2027 ($ MILLION)
FIGURE 18 EUROPE 3D CELL CULTURE MARKET BY REAGENTS AND
CONSUMABLES 2019-2027 ($ MILLION)
FIGURE 19 EUROPE 3D CELL CULTURE MARKET BY
BIOTECHNOLOGY AND PHARMACEUTICAL ORGANIZATIONS 2019-2027 ($ MILLION)
FIGURE 20 EUROPE 3D CELL CULTURE MARKET BY RESEARCH
LABORATORIES AND INSTITUTES 2019-2027 ($ MILLION)
FIGURE 21 EUROPE 3D CELL CULTURE MARKET BY HOSPITALS
AND DIAGNOSTIC CENTERS 2019-2027 ($ MILLION)
FIGURE 22 EUROPE 3D CELL CULTURE MARKET BY OTHER
END-USERS 2019-2027 ($ MILLION)
FIGURE 23 GERMANY 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 24 THE UNITED KINGDOM 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)
FIGURE 25 FRANCE 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 26 SPAIN 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 27 ITALY 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 28 RUSSIA 3D CELL CULTURE MARKET 2019-2027 ($
MILLION)
FIGURE 29 REST OF EUROPE 3D CELL CULTURE MARKET
2019-2027 ($ MILLION)